Observation on adverse reactions and nursing intervention effect of adsorbed diphtheria,tetanus and acellular pertussis combined vaccine

ZHONG Qing, LIAO Yong

Anhui Journal of Preventive Medicine ›› 2019, Vol. 25 ›› Issue (6) : 476-478.

PDF(800 KB)
PDF(800 KB)
Anhui Journal of Preventive Medicine ›› 2019, Vol. 25 ›› Issue (6) : 476-478.

Observation on adverse reactions and nursing intervention effect of adsorbed diphtheria,tetanus and acellular pertussis combined vaccine

  • ZHONG Qing1, LIAO Yong2
Author information +
History +

Abstract

Objective To investigate the adverse reactions of adsorbed diphtheria,tetanus and acellular pertussis combined vaccine (DTaP) and observe the effect of nursing intervention. Methods The adverse reactions of children vaccinated with DTaP in outpatient clinics of Ganxian Center for Disease Control and Prevention in 2018 were observed,and the effects of nursing intervention were followed up.Descriptive epidemiological methods were used to analyze the adverse reactions. Results 11 140 children were monitored for DTaP inoculation,121 of them had adverse reactions,the incidence rate was 108.66.18/100,000,the male-female ratio was 1.63:1.The incidence of adverse reactions in the first to fourth doses were 202.91/100,000,981.77/100,000,104.67/100,000 and 186.33/100,000,respectively.90.09% (109/121) of them had adverse reactions in 48 hours.Mild (grade 1) adverse reactions was the main one,accounting for 78.51%.121 children with adverse reactions were cured after timely nursing intervention. Conclusion DTaP can cause adverse reactions to varying degrees after inoculation.Nursing intervention measures should be given in time.

Key words

DTaP / Vaccination / Adverse reactions / Nursing intervention

Cite this article

Download Citations
ZHONG Qing, LIAO Yong. Observation on adverse reactions and nursing intervention effect of adsorbed diphtheria,tetanus and acellular pertussis combined vaccine[J]. Anhui Journal of Preventive Medicine. 2019, 25(6): 476-478

References

[1] 骆晓艳,高志刚,李永成,等.无细胞百白破联合疫苗/白喉破伤风联合疫苗接种后硬结反应观察及消退影响因素分析[J].中国疫苗和免疫,2017,23(2):191-195.
[2] 谢亚利,李汉华,李贺兰,等.百白破疫苗接种不良反应原因分析及预防对策[J].中国自然医学杂志,2009,11(6):446-448.
[3] 严晓英.148例儿童预防接种副反应处理[J].安徽预防医学杂志,2009,15(6):465.
[4] 国家卫生和计划生育委员会.预防接种工作规范 (2016年版)[S].北京: 国家卫生和计划生育委员会,2016.
[5] 国家食品药品监督管理局.预防用疫苗临床试验不良反应分级标准指导原则(国食药监注[2005] 493号)[S].2005-10-14.
[6] 汪娟.1991 例百白破(无细胞)疫苗不良反应回顾性分析[J].安徽医药,2014,18(2): 297-298.
[7] 夏宪照,罗会明.实用预防接种手册[M].第2 版,北京: 人民卫生出版社,2010: 289-292.
[8] 李革.接种吸附百白破疫苗后出现硬结反应182例分析[J].中国伤残医学,2013,21(8): 396-397.
[9] 谭洁瑜.儿童白破联合疫苗接种护理干预效果探讨[J].临床监护,2018,18(53):238-239.
[10] 张克美.预防接种门诊的护理安全管理体会[J].安徽预防医学杂志,2018,24(1):74-75.
PDF(800 KB)

Accesses

Citation

Detail

Sections
Recommended

/